One-year access to more than 500 world journals available in the system
http://medilib.ir
- Duration of Time : 365 Day
Price
: 300$
- Special Price
: 100$
Order
Journals package 3months
http://medilib.ir
- Duration of Time : 93 Day
Price
: 100$
- Special Price
: 50$
Order
Response to Papp et al, “Efficacy and safety of ESK-001, a highly selective, oral allosteric TYK2 inhibitor, in patients with moderate-to-severe plaque psoriasis: 52-week results from the long-term phase 2 study in patients who participated in the phase 2 STRIDE study�
doi : 10.1016/j.jaad.2025.10.091
Buy The Package and View The Article Online
Response to Chen et al’s “Risk of major adverse cardiovascular events and venous thromboembolic events between patients with psoriasis or psoriatic arthritis on tumor necrosis factor inhibitors, interleukin 17 inhibitors, interleukin 12/23 inhibitors, and interleukin 23 inhibitors: An emulated target trial analysis�
doi : 10.1016/j.jaad.2025.08.129
Buy The Package and View The Article Online